Transgender and Gender-Diverse Breast Cancer Screening Pilot - Trial NCT06383026
Access comprehensive clinical trial information for NCT06383026 through Pure Global AI's free database. This phase not specified trial is sponsored by Medical College of Wisconsin and is currently Recruiting. The study focuses on Breast Cancer. Target enrollment is 130 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Medical College of Wisconsin
Timeline & Enrollment
N/A
Apr 17, 2024
Feb 01, 2028
Primary Outcome
Callback and Biopsy Rates after Breast Cancer Screening,Reflexive Thematic Analysis of the Physical, Cognitive, and Emotional Experience of Breast Cancer Screening in Transgender and Gender Diverse Persons,Reflexive Thematic Analysis on the Individual & System-Level Barriers to Breast Cancer Screening
Summary
This investigation is a prospective breast cancer screening study open to all transgender and
 gender-diverse persons (regardless of sex assigned at birth). Using a mixed methods approach,
 the study will 1) gather prospective quantitative breast imaging data in conjunction with
 gender-affirming therapy and family cancer history and 2) investigate TGD persons perceptions
 and experiences in the breast cancer screening program, and 3) identify individual and
 systems-level barriers to breast cancer screening.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06383026
Non-Device Trial